<img alt="" height="1" width="1" />
ECTRIMS: Cancer Drug Wins in Early MS Trial
MedPage Today
AMSTERDAM -- A low-dose regimen of the leukemia drug alemtuzumab (Lemtrada) slashed annualized relapse rates in patients with newly diagnosed multiple sclerosis in a head-to-head trial against ...
Sanofi says Lemtrada helps MS patients in studyReuters
Sanofi Says Lemtrada Helps More MS Patients Than Rebif in TrialBusinessWeek
Sanofi&#39;s Lemtrada Helps MS Patients More Than Rebif In Phase III TrialRTT News
Fox Business -MarketWatch (press release)
all 32 news articles &raquo;